An overview of resistance to chemotherapy in osteosarcoma and future perspectives.
Published in Cancer drug resistance (Alhambra, Calif.) • Jan 1, 2022
Authors:,,
Dorian Yarih Garcia-Ortega
Sara Aileen Cabrera-Nieto
Haydee Sarai Caro-Sánchez
Abstract
Osteosarcoma (OS) is the most common type of bone sarcoma. Despite the availability of multimodal treatment with surgery and chemotherapy, the clinical results remain unsatisfactory. The main reason for the poor outcomes in patients with OS is the development of resistance to methotrexate, cisplatin...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!